Hedeker Wealth LLC lifted its stake in CVS Health Corp (NYSE:CVS) by 1.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 22,996 shares of the pharmacy operator’s stock after acquiring an additional 226 shares during the quarter. Hedeker Wealth LLC’s holdings in CVS Health were worth $1,343,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of CVS. Hoover Financial Advisors Inc. acquired a new stake in shares of CVS Health in the second quarter worth $32,000. Ellis Investment Partners LLC lifted its holdings in CVS Health by 47.0% during the third quarter. Ellis Investment Partners LLC now owns 541 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 173 shares during the period. Exchange Traded Concepts LLC bought a new stake in CVS Health during the second quarter worth $41,000. Keebeck Wealth Management LLC bought a new stake in CVS Health during the second quarter worth $42,000. Finally, Campbell Wealth Management bought a new stake in CVS Health during the second quarter worth $49,000. Hedge funds and other institutional investors own 75.88% of the company’s stock.
A number of brokerages recently commented on CVS. SVB Leerink lifted their price target on CVS Health from $72.00 to $73.00 and gave the stock a “market perform” rating in a report on Thursday, August 6th. Piper Sandler began coverage on CVS Health in a report on Thursday, September 17th. They set an “overweight” rating and a $72.00 price target on the stock. Deutsche Bank Aktiengesellschaft dropped their price target on CVS Health from $109.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. Credit Suisse Group lifted their price target on CVS Health from $75.00 to $90.00 and gave the stock an “outperform” rating in a report on Friday, August 7th. Finally, Royal Bank of Canada restated a “buy” rating on shares of CVS Health in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $82.33.
CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.64 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.71. The company had revenue of $65.30 billion for the quarter, compared to the consensus estimate of $64.29 billion. CVS Health had a return on equity of 16.32% and a net margin of 3.13%. The firm’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.89 EPS. As a group, equities analysts expect that CVS Health Corp will post 7.22 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be issued a $0.50 dividend. The ex-dividend date is Wednesday, October 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.49%. CVS Health’s payout ratio is 28.25%.
CVS Health Company Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Featured Story: Cost of Equity For A Business, Investors
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.